SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001370053-20-000051
Filing Date
2020-08-10
Accepted
2020-08-10 08:12:12
Documents
62
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q anab-20200630.htm   iXBRL 10-Q 1636592
2 EX-31.1 anab-63020x10qxexx311.htm EX-31.1 9760
3 EX-31.2 anab-63020x10qxexx312.htm EX-31.2 9568
4 EX-32.1 anab-63020x10qxexx321.htm EX-32.1 6133
5 EX-32.2 anab-63020x10qxexx322.htm EX-32.2 5929
11 PIPELINE CHART anab-20200630_g1.jpg GRAPHIC 149691
  Complete submission text file 0001370053-20-000051.txt   6662731

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anab-20200630.xsd EX-101.SCH 39035
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anab-20200630_cal.xml EX-101.CAL 62381
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anab-20200630_def.xml EX-101.DEF 152557
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT anab-20200630_lab.xml EX-101.LAB 471102
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anab-20200630_pre.xml EX-101.PRE 282647
12 EXTRACTED XBRL INSTANCE DOCUMENT anab-20200630_htm.xml XML 1130766
Mailing Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37985 | Film No.: 201087202
SIC: 2834 Pharmaceutical Preparations